Kisoji

Xaira

The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.

Totient

This biotechnology company develops antibody therapeutics and identifies tissue-specific antigens for drug discovery using an artificial intelligence platform.

TenSixty Bio

The company develops an artificial intelligence platform to discover tumor-selective epitopes and create antibody-based therapeutics for healthcare providers and oncology patients.

Nabla Bio

This company develops generative artificial intelligence and high-throughput screening platforms to design therapeutic antibodies for pharmaceutical and biotechnology partners.

Computational drug discovery platform

This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.

Converge Bio

The company develops AI software for antibody design and optimization to assist pharmaceutical firms in drug discovery and development.

ATB Therapeutics

The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.

Bambusa Therapeutics

The company develops bispecific antibodies for patients with immunological and inflammatory disorders.